---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008817"
form_type: "8-K"
ticker: "ONMD"
cik: "0001849380"
company_name: "OneMedNet Corp"
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T20:38:22.450096+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# OneMedNet appoints Dr. Kenneth Alleyne to Board as Class III Director

## Summary
- Board size increased to nine directors; Dr. Alleyne fills new vacancy.
- Dr. Alleyne appointed to Audit Committee; deemed independent under Nasdaq rules.
- No family relationships or arrangements with other directors/officers; standard non-employee director compensation.
- Indemnity agreement to be entered in same form as with other non-management directors.

## SEC filing metadata
- accession: 0001493152-25-008817
- form_type: 8-K
- ticker: ONMD
- cik: 0001849380
- company_name: OneMedNet Corp
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1849380/000149315225008817/0001493152-25-008817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1849380/000149315225008817/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008817
- JSON: https://secwatch.observer/filing/0001493152-25-008817.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008817.txt

## Key facts
- Executive change
  Dr. Kenneth Alleyne was appointed as Class III Director at OneMedNet Corp.
  - Action: appointed
  - Role: Class III Director
  source text: the Board appointed Dr. Kenneth Alleyne to serve as a Class III Director of the Board to fill the vacancy created by the expansion of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1849380/000149315225008817/0001493152-25-008817-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.